By Hanna Vioque ( April 29, 2026, 5:58 PM BST) -- Pfizer and BioNTech have convinced European appellate officials to nix a Moderna patent for a COVID-19 jab, after showing that its patented claims added details that weren't in the original application about which virus-fighting protein the body needed to make and how. ...
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.